Healthcare IT News July 7, 2023
The company told the American Diabetes Association that the metabolic monitor could reduce down-the-line healthcare costs for T2 non-insulin users and others. “These trends have to change,” says CEO Kevin Sayer.
Dexcom, a maker of continuous glucose monitors, is developing a Type 2 diabetes monitor for those who don’t need insulin that has a 15-day sensor and a cash-pay option for patients not covered by Medicare and health insurers that want daily decision support.
With the number of diabetes-affected Americans numbering more than 37 million, according to the U.S. Centers for Disease Control, healthcare technology developers and researchers seek to enhance the prevention, early detection, management and care of diabetes.
“There are three key decisions that somebody with Type...
Today's Sponsors
Today's Sponsor